Clinical Trial

Lidocaine vs Magnesium Sulfate for Hemodynamic Stability During Emergence in Infertility-Related Laparoscopic Surgery"

Study acronym: LidoMagGyna
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2026 (before its estimated July 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is being conducted to compare two medications, intravenous lidocaine and intravenous magnesium sulfate, and their ability to keep blood pressure and heart rate stable during the period of waking up from general anesthesia in infertility-related laparoscopic gynecologic surgeries. Laparoscopic gynecologic procedures can cause changes in heart rate and blood pressure, especially during emergence from anesthesia, and these changes may affect patient safety. In this randomized, double-blind clinical trial, women scheduled for elective infertility-related laparoscopic surgery will be assigned to one of three groups: lidocaine, magnesium sulfate, or a control group. The study will evaluate mean arterial pressure (primary outcome), heart rate, pain scores, sedation level, nausea and vomiting, and any side effects during and after surgery. The goal is to determine which medication provides better hemodynamic stability and improves recovery in the early postoperative period.
Trial Details
NCT Number NCT07359560
Lead Sponsor Zagazig University
Conditions Infertility Female, Hemodynamic Instability
Enrollment 69 participants
Start Date 2026-01-02
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-22